IDEX Biometrics ASA (OSL:IDEX)
9.00
-0.38 (-4.05%)
Jun 4, 2026, 12:54 PM CET
IDEX Biometrics ASA Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.72 | 2.01 | 11.35 | 16.12 | 33.76 |
Cash & Short-Term Investments | 0.72 | 2.01 | 11.35 | 16.12 | 33.76 |
Cash Growth | -64.43% | -82.29% | -29.60% | -52.24% | 362.58% |
Accounts Receivable | 0.05 | 0.03 | 0.95 | 1.35 | 0.8 |
Other Receivables | 0.32 | 0.9 | 0.98 | 0.93 | 0.7 |
Receivables | 0.37 | 0.93 | 1.93 | 2.28 | 1.5 |
Inventory | 5.68 | 5.55 | 6.38 | 4.45 | 1.23 |
Prepaid Expenses | 0.29 | 0.76 | 0.65 | 0.99 | 0.85 |
Other Current Assets | - | 0 | - | - | - |
Total Current Assets | 7.06 | 9.26 | 20.31 | 23.84 | 37.35 |
Property, Plant & Equipment | 0.05 | 0.42 | 2.59 | 2.65 | 1.66 |
Goodwill | - | - | 0.97 | 0.97 | 0.97 |
Other Intangible Assets | 0.47 | 0.57 | 1.01 | 1.49 | 1.97 |
Other Long-Term Assets | 0.06 | 0.06 | 0.08 | 0.07 | 0.09 |
Total Assets | 7.64 | 10.3 | 24.96 | 29.02 | 42.03 |
Accounts Payable | 1.16 | 0.85 | 0.69 | 1.54 | 0.69 |
Accrued Expenses | 0.07 | 0.27 | 0.28 | 0.39 | 0.39 |
Current Portion of Long-Term Debt | 1.09 | - | 8.62 | - | - |
Current Portion of Leases | 0.08 | 0.4 | 0.62 | 0.4 | 0.36 |
Other Current Liabilities | 2.06 | 1.95 | 2.17 | 2.7 | 2.85 |
Total Current Liabilities | 4.46 | 3.46 | 12.39 | 5.03 | 4.29 |
Long-Term Debt | 1.72 | 2.12 | - | - | - |
Long-Term Leases | - | - | 1.24 | 1.14 | 0.01 |
Other Long-Term Liabilities | - | 0 | - | - | - |
Total Liabilities | 6.18 | 5.58 | 13.63 | 6.18 | 4.3 |
Common Stock | 6.21 | 12.94 | 25.96 | 22.76 | 20.41 |
Additional Paid-In Capital | 2.65 | 1.74 | 2.12 | 4.04 | 9.45 |
Retained Earnings | 5.25 | -344.48 | -330.03 | -303.4 | -270.74 |
Comprehensive Income & Other | -12.65 | 334.51 | 313.29 | 299.44 | 278.6 |
Shareholders' Equity | 1.46 | 4.71 | 11.33 | 22.84 | 37.73 |
Total Liabilities & Equity | 7.64 | 10.3 | 24.96 | 29.02 | 42.03 |
Total Debt | 2.89 | 2.52 | 10.48 | 1.54 | 0.37 |
Net Cash (Debt) | -2.18 | -0.51 | 0.87 | 14.58 | 33.39 |
Net Cash Growth | - | - | -94.04% | -56.33% | 435.03% |
Net Cash Per Share | -0.06 | -0.12 | 0.34 | 7.10 | 18.17 |
Filing Date Shares Outstanding | 62.6 | 8.32 | 2.8 | 2.34 | 2.03 |
Total Common Shares Outstanding | 62.6 | 8.32 | 2.79 | 2.33 | 2.02 |
Working Capital | 2.6 | 5.79 | 7.92 | 18.8 | 33.06 |
Book Value Per Share | 0.02 | 0.57 | 4.06 | 9.79 | 18.67 |
Tangible Book Value | 0.99 | 4.14 | 9.36 | 20.39 | 34.79 |
Tangible Book Value Per Share | 0.02 | 0.50 | 3.35 | 8.74 | 17.22 |
Machinery | - | - | 4.27 | 4.12 | 3.92 |